Patents by Inventor Katrin Atnikov

Katrin Atnikov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • XYXIN FRAGMENT BIOMARKER FOR DIAGNOSIS OF COLON CANCER
    Publication number: 20130323253
    Abstract: The present invention relates to the field of the diagnosis of large intestine/colon diseases. More particularly, the present invention provides a method for differential diagnosis of colorectal cancer from a non-malignant disease of the large intestine/colon, and from a healthy large intestine/colon. The invention also relates to treatment of colorectal cancer.
    Type: Application
    Filed: June 1, 2011
    Publication date: December 5, 2013
    Applicant: MIRACULINS, INC.
    Inventors: Douglas Barker, Katrin Atnikov, Yilan Zhang, Stephen Frost
  • BIOMARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER IN A NON-HYPERTENSIVE POPULATION
    Publication number: 20120022793
    Abstract: The present invention includes the use of biomolecules for differential diagnosis of prostate cancer and/or non-malignant disease of the prostate. The present invention also provides methods for detecting biomolecules within a biological sample. The invention further includes kits for differential diagnosis of prostate cancer and/or non-malignant disease of the prostate in a biological sample.
    Type: Application
    Filed: July 22, 2011
    Publication date: January 26, 2012
    Applicant: Miraculins, Inc.
    Inventors: Douglas BARKER, Katrin Atnikov, Yilan Zhang, Stephen Frost
  • DIAGNOSTIC ASSAYS FOR PROSTATE CANCER USING PSP94 AND PSA BIOMARKERS
    Publication number: 20120021925
    Abstract: The application refers to a method for diagnosing prostate cancer through the measurement of the combination of PSP94 (?-microseminoprotein) and F/T PSA biomarkers, the method using urine samples to measure PSP94 and serum samples to analyse F/T PSA. In one embodiment, the PSP94 is standardized to creatinine. Also based on the measurement of PSP94 and F/T PSA are provided methods and kits for (a) diagnosing aggressive prostate cancer; (b) differential diagnosis; and (c) diagnosing the progression of prostate cancer.
    Type: Application
    Filed: January 19, 2010
    Publication date: January 26, 2012
    Applicant: MIRACULINS, INC.
    Inventors: Katrin Atnikov, Douglas Barker, Yilan Zhang, Stephen Frost